Mangoceuticals, Inc. (MGRX) stock
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$0.15−0.01 (-8.44%)
Close on Nov 18, 2026Market cap $3.16MP/E –Yield –
Mangoceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Mangoceuticals's free cash flow for the twelve months ending Dec 31, 2023 was -$7.00M. For fiscal 2023 it was -$7.00M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$7.00M | – |
| FY2022 | Dec 31, 2022 | -$1.39M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$1.70M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.71M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.78M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.81M | – |
| Q4 FY2022 | Dec 31, 2022 | -$690.13K | – |
See a number that looks wrong?